46.295708, 7.883808
Lonza
Visp, Switzerland
- Verified lead
- Renzo Cicillini
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Site Head Visp
- 2026 technical specialization
- Commercial Biologics Manufacturing and CDMO Infrastructure
- Review cycle
- May 2026
- Full address
- Rottenstrasse 6, CH-3930 Visp, Switzerland
- Site coordinates
- 46.295708, 7.883808
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Lonza Visp leadership team page confirming Renzo Cicillini as Site Head Visp.
- Editorial note
- Commercial GMP biologics backbone with large-scale mammalian and microbial suites, multiproduct fill-finish, and global analytical release capability.
Commercial Biologics Manufacturing and CDMO Infrastructure
GMP Manufacturing, Commercial Biologics Quality Systems
Commercial GMP biologics backbone with large-scale mammalian and microbial suites, multiproduct fill-finish, and global analytical release capability.

Lonza
Commercial Biologics Manufacturing and CDMO Infrastructure · Global commercial CDMO
Commercial GMP biologics backbone with large-scale mammalian and microbial suites, multiproduct fill-finish, and global analytical release capability.
- Lead
- Renzo Cicillini (verified ↗)
- Address
- Rottenstrasse 6, CH-3930 Visp, Switzerland (source ↗)
- Compliance
- GMP Manufacturing
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global commercial CDMO
- Capabilities
- Mammalian Cell Culture · Microbial Manufacturing · Drug Substance and Drug Product CDMO Services
- Founded
- 1897
- Headcount
- 10000+
- Company page (open ↗)

Renzo Cicillini
Site Head Visp
Global commercial CDMO
Visp, Switzerland. Commercial Biologics Manufacturing and CDMO Infrastructure. Review completed on 14 Mar 2026.
Swissmedic, EMA, FDA, and global biologics oversight
GMP Manufacturing, Commercial Biologics Quality Systems
Commercial Biologics Manufacturing and CDMO Infrastructure
Commercial GMP biologics backbone with large-scale mammalian and microbial suites, multiproduct fill-finish, and global analytical release capability.
Lonza anchors the Swiss manufacturing layer through current executive verification and an official biologics manufacturing surface.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Lonza located?
- Lonza operates from Rottenstrasse 6, CH-3930 Visp, Switzerland, Visp, Switzerland.
- Who runs Lonza?
- Lonza is led by Renzo Cicillini, Site Head Visp. Verified 14 Mar 2026.
- What certifications does Lonza hold?
- Lonza is documented under GMP Manufacturing.
- What does Lonza do?
- Commercial GMP biologics backbone with large-scale mammalian and microbial suites, multiproduct fill-finish, and global analytical release capability. Core capabilities: Mammalian Cell Culture, Microbial Manufacturing, Drug Substance and Drug Product CDMO Services.
Related technical briefs
Briefs that name Visp as a covered market or city.
